58 related articles for article (PubMed ID: 3309858)
1. Murine responses to immunization with pertussis toxin and bovine serum albumin: I. Mortality observed after bovine albumin challenge is due to an anaphylactic reaction.
Wiedmeier SE; Chung HT; Cho BH; Kim UH; Daynes RA
Pediatr Res; 1987 Sep; 22(3):262-7. PubMed ID: 3309858
[TBL] [Abstract][Full Text] [Related]
2. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
[TBL] [Abstract][Full Text] [Related]
3. Is the acute encephalopathy test in mice suited for control of pertussis vaccines?
Au-Jensen M; Heron I
Dev Biol Stand; 1985; 61():447-51. PubMed ID: 3835081
[TBL] [Abstract][Full Text] [Related]
4. Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin).
Munoz JJ; Peacock MG; Hadlow WJ
Infect Immun; 1987 Apr; 55(4):1004-8. PubMed ID: 3557617
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin is required for pertussis vaccine encephalopathy.
Steinman L; Weiss A; Adelman N; Lim M; Zuniga R; Oehlert J; Hewlett E; Falkow S
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8733-6. PubMed ID: 2867545
[TBL] [Abstract][Full Text] [Related]
6. The activity of purified Bordetella pertussis components in murine encephalopathy.
Redhead K; Robinson A; Ashworth LA; Melville-Smith M
J Biol Stand; 1987 Oct; 15(4):341-51. PubMed ID: 3680302
[TBL] [Abstract][Full Text] [Related]
7. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
Burnette WN
Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
[TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.
Kimura A; Mountzouros KT; Schad PA; Cieplak W; Cowell JL
Infect Immun; 1990 Oct; 58(10):3337-47. PubMed ID: 2119344
[TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking and membrane translocation of pertussis toxin into host cells.
Veithen A; Raze D; Locht C
Int J Med Microbiol; 2000 Oct; 290(4-5):409-13. PubMed ID: 11111919
[TBL] [Abstract][Full Text] [Related]
10. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
Zhu J; Li W; Toews ML; Hexum TD
J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
[TBL] [Abstract][Full Text] [Related]
12. ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis.
Black WJ; Munoz JJ; Peacock MG; Schad PA; Cowell JL; Burchall JJ; Lim M; Kent A; Steinman L; Falkow S
Science; 1988 Apr; 240(4852):656-9. PubMed ID: 2896387
[TBL] [Abstract][Full Text] [Related]
13. Biochemical properties of pertussis toxin.
Burns DL; Hausman SZ; Witvliet MH; Brennan MJ; Poolman JT; Manclark CR
Tokai J Exp Clin Med; 1988; 13 Suppl():181-5. PubMed ID: 2856219
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antibodies elicited by immunization with pertussis toxin.
Kaslow HR; Schlotterbeck JD; Gotto J
Dev Biol Stand; 1991; 73():143-50. PubMed ID: 1778308
[TBL] [Abstract][Full Text] [Related]
15. Studies on the immunizing capacity of orally administered particulate antigens. I. The efficiency of killed Bordetella pertussis cells.
Hof H; Finger H; Körner L; Milcke L
Zentralbl Bakteriol Orig A; 1975; 230(2):210-22. PubMed ID: 167535
[TBL] [Abstract][Full Text] [Related]
16. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
Yue TL; Stadel JM; Sarau HM; Friedman E; Gu JL; Powers DA; Gleason MM; Feuerstein G; Wang HY
Mol Pharmacol; 1992 Feb; 41(2):281-9. PubMed ID: 1311408
[TBL] [Abstract][Full Text] [Related]
18. Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying.
Blumberg DA; Lewis K; Mink CM; Christenson PD; Chatfield P; Cherry JD
Pediatrics; 1993 Jun; 91(6):1158-65. PubMed ID: 8502521
[TBL] [Abstract][Full Text] [Related]
19. Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability.
Garcia JG; Wang P; Schaphorst KL; Becker PM; Borbiev T; Liu F; Birukova A; Jacobs K; Bogatcheva N; Verin AD
FASEB J; 2002 Jul; 16(9):1064-76. PubMed ID: 12087068
[TBL] [Abstract][Full Text] [Related]
20. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
